Post by ClarityES1

𝗧𝗵𝗲 𝗜𝗗𝗡 𝗣𝗮𝗿𝗮𝗱𝗼𝘅 𝙒𝙝𝙮 𝙂𝙚𝙩𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙈𝙚𝙚𝙩𝙞𝙣𝙜 𝙄𝙨𝙣’𝙩 𝙩𝙝𝙚 𝙒𝙞𝙣 Your KAM team finally got the meeting with the IDN C-suite. Congratulations... now comes the hard part that most teams get completely wrong. Over 17 years, I've watched countless Pharma and MedTech teams celebrate landing the IDN meeting, only to show up unprepared for the strategic conversation that decision-makers actually want to have. The paradox? Your team spent months earning the right to be in the room. But they walked in with a product pitch in their heads instead of a business strategy. IDN executives don't care about your drug portfolio. They care about their cost per episode, their quality metrics, their population health outcomes. The meeting isn't where you sell—it's where you prove you understand THEIR business well enough to be a strategic partner. Strategic KAMs ask different questions b̲e̲f̲o̲r̲e̲ the meeting: • What are this IDN's top 3 business priorities this year? • Which of our capabilities directly impact those priorities? • What does success look like from THEIR perspective? If your team can't answer these questions before walking in, you haven't earned a strategic conversation—you've earned a polite dismissal. What questions are your KAMs asking b̲e̲f̲o̲r̲e̲ IDN meetings? #KeyAccountManagement #PharmaSales #StrategicAccounts #IDNStrategy